{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:20:50Z","timestamp":1790626850215,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.jaci.2003.12.039","type":"journal-article","created":{"date-parts":[[2004,3,6]],"date-time":"2004-03-06T05:39:45Z","timestamp":1078551585000},"page":"503-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["(S)-Albuterol activates pro-constrictory and pro-inflammatory pathways in human bronchial smooth muscle cells"],"prefix":"10.1016","volume":"113","author":[{"given":"Devendra K","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishan","family":"Ariyarathna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W","family":"Kelbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2003.12.039_BIB1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJM199508243330807","article-title":"\u03b2-Adrenergic bronchodilators","volume":"333","author":"Nelson","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2003.12.039_BIB2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0025-7125(02)00031-7","article-title":"Beta-agonists","volume":"86","author":"Dutta","year":"2002","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jaci.2003.12.039_BIB3","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0140-6736(90)93098-A","article-title":"Regular inhaled beta-agonist treatment in bronchial asthma","volume":"336","author":"Sears","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2003.12.039_BIB4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM199202203260801","article-title":"The use of \u03b2-agonists and the risk of death and near death from asthma","volume":"326","author":"Spitzer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2003.12.039_BIB5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0091-6749(95)70031-5","article-title":"Regular use of inhaled albuterol and the allergen-induced late asthmatic response","volume":"96","author":"Cockcraft","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00063198-200001000-00009","article-title":"New millennium bronchodilators for asthma: single isomer beta gonists","volume":"6","author":"Handley","year":"2000","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jaci.2003.12.039_BIB7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s002280050640","article-title":"Bronchoprotective and bronchodilator effects of single doses of (S)-salbutamol, (R)-salbutamol and racemic salbutamol in patients with bronchial asthma","volume":"55","author":"Ramsay","year":"1999","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB8","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/thx.51.10.1051","article-title":"Functional antagonism: tolerance produced by inhaled \u03b22 agonists","volume":"51","author":"Cockcraft","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2003.12.039_BIB9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1254\/jjp.63.159","article-title":"Exacerbation of airway hyperreactivity by (\u00b1) salbutamol in sensitized guinea pigs","volume":"63","author":"Hoshiko","year":"1993","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/pulp.1994.1043","article-title":"Hyperresponsiveness of the airways following exposure of guinea pigs to racemic mixtures and distomers of beta2-selective sympathomimetics","volume":"7","author":"Mazzoni","year":"1994","journal-title":"Pulm Pharmacol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/pupt.1998.0110","article-title":"Effects of S-albuterol on human isolated bronchus","volume":"11","author":"Templeton","year":"1998","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jaci.2003.12.039_BIB12","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1067\/mai.2001.119152","article-title":"The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients","volume":"108","author":"Lotvall","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1067\/mai.2001.119407","article-title":"Levalbuterol and racemic albuterol: are there therapeutic differences?","volume":"108","author":"Ahrens","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1197\/aemj.9.5.404-a","article-title":"Inverse correlations between (S)-albuterol levels and FEV1 in the emergency department [abstract]","volume":"9","author":"Emerman","year":"2002","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jaci.2003.12.039_BIB15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1159\/000053783","article-title":"(S)-albuterol increases the production of histamine and IL-4 in mast cells","volume":"124","author":"Cho","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1067\/mai.2002.122159","article-title":"Modulation of T-cell function by (R)- and (S)-isomers of albuterol: Anti-inflammatory influences of (R)-isomers are negated in the presence of the (S)-isomer","volume":"109","author":"Baramki","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl","key":"10.1016\/j.jaci.2003.12.039_BIB17","first-page":"S35","article-title":"Pro- and anti-inflammatory effects of \u03b2-adrenergic agonists on eosinophil response to IL-5 [abstract]","volume":"101","author":"Volchek","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/pupt.1997.0082","article-title":"Effect of enantiomeric forms of albuterol on stimulated secretion of granular protein from human eosinophils","volume":"10","author":"Leff","year":"1997","journal-title":"Pulm Pharmacol Ther"},{"issue":"suppl","key":"10.1016\/j.jaci.2003.12.039_BIB19","doi-asserted-by":"crossref","first-page":"S292","DOI":"10.1016\/S0091-6749(00)91286-7","article-title":"Cytosine, chemokine, and nitric oxide (NO) release in stimulated small airway epithelial cells (SAEC) treated with beta2-agonist enantiomers of albuterol [abstract]","volume":"105","author":"Frieri","year":"2000","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl","key":"10.1016\/j.jaci.2003.12.039_BIB20","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1164\/ajrccm.158.supplement_2.13tac110","article-title":"The beta-adrenoceptor","volume":"158","author":"Johnson","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2003.12.039_BIB21","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1165\/ajrcmb.21.5.3759","article-title":"Inflammatory and contractile agents sensitize specific adenylyl cyclase isoforms in human airway smooth muscle","volume":"21","author":"Billington","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1124\/mol.53.3.347","article-title":"(S)-albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C-dependent mechanism in airway smooth muscle","volume":"53","author":"Mitra","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB23","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.1074\/jbc.272.11.7338","article-title":"Heterogeneity in beta-adrenergic receptor kinase expression in the lung accounts for cell-specific desensitization of the beta2-adrenergic receptor","volume":"272","author":"McGraw","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2003.12.039_BIB24","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1054-3589(08)60777-2","article-title":"Mechanisms of beta-adrenergic receptor desensitization and resensitization","volume":"42","author":"Lefkowitz","year":"1998","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB25","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","article-title":"A new generation of Ca2+ indicators with greatly improved fluorescence properties","volume":"260","author":"Grynkiewicz","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2003.12.039_BIB26","doi-asserted-by":"crossref","first-page":"30279","DOI":"10.1074\/jbc.273.46.30279","article-title":"Lipid products of phosphoinositide 3-kinase interact with Rac1 GTPase and stimulate GDP dissociation","volume":"273","author":"Missy","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2003.12.039_BIB27","doi-asserted-by":"crossref","first-page":"30199","DOI":"10.1074\/jbc.273.46.30199","article-title":"Regulation of the p85\/p110\u03b1 phosphatidylinositol 3\u03b6-kinase: distinct roles for the N-terminal and C-terminal SH2 domains","volume":"273","author":"Yu","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2003.12.039_BIB28","first-page":"191A","article-title":"Differential effects of albuterol enantiomers on pulmonary functions and bronchoalveolar lavage (BAL) eosinophilia [abstract]","volume":"161","author":"Agrawal","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2003.12.039_BIB29","first-page":"L32","article-title":"Effects of enantiomers of \u03b22-agonists on Ach release and smooth muscle contraction in the trachea","volume":"74","author":"Zhang","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02772203","article-title":"Effects of albuterol enantiomers on in vitro bronchial reactivity","volume":"14","author":"Johansson","year":"1996","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02772208","article-title":"Differential responses of asthmatic airways to enantiomers of albuterol","volume":"14","author":"Perrin-Fayolle","year":"1996","journal-title":"Clin Rev Allergy Immunol"},{"issue":"suppl","key":"10.1016\/j.jaci.2003.12.039_BIB32","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0091-6749(99)70276-9","article-title":"The asthma-like pharmacology and toxicology of (S)-isomers of \u03b2-agonists","volume":"104","author":"Handley","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB33","doi-asserted-by":"crossref","first-page":"33082","DOI":"10.1074\/jbc.273.49.33082","article-title":"Human phosphoinositide 3-kinase C2\u03b2, the role of calcium and the C2 domain in enzyme activity","volume":"273","author":"Arcaro","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2003.12.039_BIB34","doi-asserted-by":"crossref","first-page":"28096","DOI":"10.1074\/jbc.272.44.28096","article-title":"G-protein-coupled receptors and Fcgamma-receptors mediate activation of Akt\/protein kinase B in human phagocytes","volume":"272","author":"Tilton","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2003.12.039_BIB35","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood.V91.7.2547","article-title":"Analysis of signal transduction pathways in human eosinophils activated by chemoattractants and the T-helper-2-derived cytokines interleukin-4 and interleukin-5","volume":"91","author":"Coffer","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2003.12.039_BIB36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0014-5793(97)00518-8","article-title":"cAMP stimulates protein kinase B in a Wortmannin-insensitive manner","volume":"409","author":"Sable","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaci.2003.12.039_BIB37","doi-asserted-by":"crossref","first-page":"18953","DOI":"10.1074\/jbc.M102376200","article-title":"Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by beta-adrenergic receptor kinase 1. A role in receptor sequestration","volume":"276","author":"Naga-Prasad","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2003.12.039_BIB38","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1357-2725(96)00159-8","article-title":"Nuclear factor-kappa B","volume":"29","author":"Barnes","year":"1997","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1165\/ajrcmb.17.1.f132","article-title":"The role of nuclear factor-kappa B in cytokine gene regulation","volume":"17","author":"Blackwell","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/83158","article-title":"A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation","volume":"2","author":"Das","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB41","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0091-6749(98)70332-X","article-title":"Improved bronchodilation with levalbuterol versus racemic albuterol in patients with asthma","volume":"102","author":"Nelson","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB42","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1183\/09031936.99.13612369","article-title":"Stereoselective pharmacokinetics of S-salbutamol after administration of the racemate in healthy volunteers","volume":"13","author":"Schmekel","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2003.12.039_BIB43","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1177\/009127009803801203","article-title":"Pharmacokinetic and pharmacodynamic characteristics and safety of inhaled albuterol enantiomers in healthy volunteers","volume":"38","author":"Gumbhir-Shah","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB44","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1164\/ajrccm.160.4.9812074","article-title":"Preferential pulmonary retention of (S)-albuterol after inhalation of racemic albuterol","volume":"160","author":"Dhand","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2003.12.039_BIB45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02772202","article-title":"(S)-Albuterol exacerbates calcium responses to carbachol in airway smooth muscle cells","volume":"14","author":"Yamaguchi","year":"1996","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF02772201","article-title":"Comparison of R-, S-, and RS-albuterol interaction with human \u03b21- and \u03b22-adrenergic receptors","volume":"14","author":"Penn","year":"1996","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/36362","article-title":"Switching of the coupling of the \u03b22-adrenergic receptor to different G proteins by protein kinase A","volume":"390","author":"Daaka","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2003.12.039_BIB48","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0165-6147(97)90685-4","article-title":"Inverse agonism and the regulation of receptor number","volume":"18","author":"Milligan","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jaci.2003.12.039_BIB49","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1067\/mai.2001.120134","article-title":"Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol","volume":"108","author":"Milgrom","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2003.12.039_BIB50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1378\/chest.123.1.128","article-title":"Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma","volume":"123","author":"Truitt","year":"2003","journal-title":"Chest"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674903028525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674903028525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:53:39Z","timestamp":1758776019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674903028525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0091674903028525"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2003.12.039","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"(S)-Albuterol activates pro-constrictory and pro-inflammatory pathways in human bronchial smooth muscle cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2003.12.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}